{
  "input": {
    "mode": "report_and_evolve",
    "query": {
      "entity": "Generalised pustular psoriasis",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_acitretin",
          "name": "Acitretin"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_apremilast",
          "name": "Apremilast"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_etanercept",
          "name": "Etanercept"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_infliximab",
          "name": "Infliximab"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_secukinumab",
          "name": "Secukinumab"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_cyclosporine",
          "name": "Cyclosporine"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_adalimumab",
          "name": "Adalimumab"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_interleukin_17_inhibitors",
          "name": "Interleukin-17 inhibitors"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_topical_corticosteroids",
          "name": "Topical corticosteroids"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_ustekinumab",
          "name": "Ustekinumab"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_thalidomide",
          "name": "Thalidomide"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "scores": [],
    "ranking": [],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "n_acitretin",
          "type": "Drug",
          "label": "Acitretin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_apremilast",
          "type": "Drug",
          "label": "Apremilast",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_etanercept",
          "type": "Drug",
          "label": "Etanercept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_secukinumab",
          "type": "Drug",
          "label": "Secukinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_cyclosporine",
          "type": "Drug",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_IL17_inhibitors",
          "type": "Drug",
          "label": "Interleukin-17 inhibitors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_topical_corticosteroids",
          "type": "Drug",
          "label": "Topical corticosteroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_thalidomide",
          "type": "Drug",
          "label": "Thalidomide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_Generalised_pustular_psoriasis",
          "type": "Disease",
          "label": "Generalised pustular psoriasis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_cutaneous_inflammation",
          "type": "Pathway",
          "label": "Cutaneous Inflammation",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_immun_modulation",
          "type": "Pathway",
          "label": "Immune Modulation",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ot_acitretin",
          "type": "Target",
          "label": "OffTargetAcitretin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_acitretin",
          "type": "Pathway",
          "label": "RiskPathwayAcitretin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_acitretin",
          "type": "Phenotype",
          "label": "AdversePhenotypeAcitretin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_apremilast",
          "type": "Target",
          "label": "OffTargetApremilast",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_apremilast",
          "type": "Pathway",
          "label": "RiskPathwayApremilast",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_apremilast",
          "type": "Phenotype",
          "label": "AdversePhenotypeApremilast",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_etanercept",
          "type": "Target",
          "label": "OffTargetEtanercept",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_etanercept",
          "type": "Pathway",
          "label": "RiskPathwayEtanercept",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_etanercept",
          "type": "Phenotype",
          "label": "AdversePhenotypeEtanercept",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_infliximab",
          "type": "Target",
          "label": "OffTargetInfliximab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_infliximab",
          "type": "Pathway",
          "label": "RiskPathwayInfliximab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_infliximab",
          "type": "Phenotype",
          "label": "AdversePhenotypeInfliximab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_secukinumab",
          "type": "Target",
          "label": "OffTargetSecukinumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_secukinumab",
          "type": "Pathway",
          "label": "RiskPathwaySecukinumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_secukinumab",
          "type": "Phenotype",
          "label": "AdversePhenotypeSecukinumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_cyclosporine",
          "type": "Target",
          "label": "OffTargetCyclosporine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_cyclosporine",
          "type": "Pathway",
          "label": "RiskPathwayCyclosporine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_cyclosporine",
          "type": "Phenotype",
          "label": "AdversePhenotypeCyclosporine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_methotrexate",
          "type": "Target",
          "label": "OffTargetMethotrexate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_methotrexate",
          "type": "Pathway",
          "label": "RiskPathwayMethotrexate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_methotrexate",
          "type": "Phenotype",
          "label": "AdversePhenotypeMethotrexate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_adalimumab",
          "type": "Target",
          "label": "OffTargetAdalimumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_adalimumab",
          "type": "Pathway",
          "label": "RiskPathwayAdalimumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_adalimumab",
          "type": "Phenotype",
          "label": "AdversePhenotypeAdalimumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_ustekinumab",
          "type": "Target",
          "label": "OffTargetUstekinumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_ustekinumab",
          "type": "Pathway",
          "label": "RiskPathwayUstekinumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_ustekinumab",
          "type": "Phenotype",
          "label": "AdversePhenotypeUstekinumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_thalidomide",
          "type": "Target",
          "label": "OffTargetThalidomide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_thalidomide",
          "type": "Pathway",
          "label": "RiskPathwayThalidomide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_thalidomide",
          "type": "Phenotype",
          "label": "AdversePhenotypeThalidomide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Acitretin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_acitretin",
          "type": "Drug",
          "label": "Acitretin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Apremilast",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_apremilast",
          "type": "Drug",
          "label": "Apremilast",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Etanercept",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_etanercept",
          "type": "Drug",
          "label": "Etanercept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Infliximab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Secukinumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_secukinumab",
          "type": "Drug",
          "label": "Secukinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_cyclosporine",
          "type": "Drug",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Methotrexate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Adalimumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Interleukin-17 inhibitors",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_interleukin_17_inhibitors",
          "type": "Drug",
          "label": "Interleukin-17 inhibitors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Topical corticosteroids",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_topical_corticosteroids",
          "type": "Drug",
          "label": "Topical corticosteroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Thalidomide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_thalidomide",
          "type": "Drug",
          "label": "Thalidomide",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "edges": [
        {
          "source": "n_acitretin",
          "target": "n_cutaneous_inflammation",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知对皮肤炎症有影响"
        },
        {
          "source": "n_apremilast",
          "target": "n_immun_modulation",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "常用于免疫调节"
        },
        {
          "source": "n_etanercept",
          "target": "n_immun_modulation",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "可有效抑制免疫反应"
        },
        {
          "source": "n_infliximab",
          "target": "n_immun_modulation",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "用于抑制炎症反应"
        },
        {
          "source": "n_secukinumab",
          "target": "n_cutaneous_inflammation",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "靶向治疗皮肤炎症"
        },
        {
          "source": "n_cyclosporine",
          "target": "n_immun_modulation",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "已知为免疫抑制剂"
        },
        {
          "source": "n_methotrexate",
          "target": "n_immun_modulation",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "使用于自身免疫疾病"
        },
        {
          "source": "n_adalimumab",
          "target": "n_immun_modulation",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "常用于免疫调节"
        },
        {
          "source": "n_IL17_inhibitors",
          "target": "n_cutaneous_inflammation",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "针对皮肤炎症机制"
        },
        {
          "source": "n_topical_corticosteroids",
          "target": "n_cutaneous_inflammation",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "广泛用于皮肤炎症"
        },
        {
          "source": "n_ustekinumab",
          "target": "n_immun_modulation",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "靶向免疫通路"
        },
        {
          "source": "n_thalidomide",
          "target": "n_immun_modulation",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "有潜在的免疫调节作用"
        },
        {
          "source": "n_cutaneous_inflammation",
          "target": "n_Generalised_pustular_psoriasis",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "与皮肤炎症密切相关"
        },
        {
          "source": "n_immun_modulation",
          "target": "n_Generalised_pustular_psoriasis",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "涉及免疫调节过程"
        },
        {
          "source": "drug_acitretin",
          "target": "n_ot_acitretin",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路作用"
        },
        {
          "source": "n_ot_acitretin",
          "target": "n_rp_acitretin",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的风险通路"
        },
        {
          "source": "n_rp_acitretin",
          "target": "n_adv_acitretin",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_acitretin",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消效益"
        },
        {
          "source": "drug_apremilast",
          "target": "n_ot_apremilast",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路作用"
        },
        {
          "source": "n_ot_apremilast",
          "target": "n_rp_apremilast",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的风险通路"
        },
        {
          "source": "n_rp_apremilast",
          "target": "n_adv_apremilast",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_apremilast",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消效益"
        },
        {
          "source": "drug_etanercept",
          "target": "n_ot_etanercept",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路作用"
        },
        {
          "source": "n_ot_etanercept",
          "target": "n_rp_etanercept",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的风险通路"
        },
        {
          "source": "n_rp_etanercept",
          "target": "n_adv_etanercept",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_etanercept",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消效益"
        },
        {
          "source": "drug_infliximab",
          "target": "n_ot_infliximab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路作用"
        },
        {
          "source": "n_ot_infliximab",
          "target": "n_rp_infliximab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的风险通路"
        },
        {
          "source": "n_rp_infliximab",
          "target": "n_adv_infliximab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_infliximab",
          "target": "H4",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消效益"
        },
        {
          "source": "drug_secukinumab",
          "target": "n_ot_secukinumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路作用"
        },
        {
          "source": "n_ot_secukinumab",
          "target": "n_rp_secukinumab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的风险通路"
        },
        {
          "source": "n_rp_secukinumab",
          "target": "n_adv_secukinumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_secukinumab",
          "target": "H5",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消效益"
        },
        {
          "source": "drug_cyclosporine",
          "target": "n_ot_cyclosporine",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路作用"
        },
        {
          "source": "n_ot_cyclosporine",
          "target": "n_rp_cyclosporine",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的风险通路"
        },
        {
          "source": "n_rp_cyclosporine",
          "target": "n_adv_cyclosporine",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_cyclosporine",
          "target": "H6",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消效益"
        },
        {
          "source": "drug_methotrexate",
          "target": "n_ot_methotrexate",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路作用"
        },
        {
          "source": "n_ot_methotrexate",
          "target": "n_rp_methotrexate",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的风险通路"
        },
        {
          "source": "n_rp_methotrexate",
          "target": "n_adv_methotrexate",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_methotrexate",
          "target": "H7",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消效益"
        },
        {
          "source": "drug_adalimumab",
          "target": "n_ot_adalimumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路作用"
        },
        {
          "source": "n_ot_adalimumab",
          "target": "n_rp_adalimumab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的风险通路"
        },
        {
          "source": "n_rp_adalimumab",
          "target": "n_adv_adalimumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_adalimumab",
          "target": "H8",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消效益"
        },
        {
          "source": "drug_ustekinumab",
          "target": "n_ot_ustekinumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路作用"
        },
        {
          "source": "n_ot_ustekinumab",
          "target": "n_rp_ustekinumab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的风险通路"
        },
        {
          "source": "n_rp_ustekinumab",
          "target": "n_adv_ustekinumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_ustekinumab",
          "target": "H11",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消效益"
        },
        {
          "source": "drug_thalidomide",
          "target": "n_ot_thalidomide",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路作用"
        },
        {
          "source": "n_ot_thalidomide",
          "target": "n_rp_thalidomide",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的风险通路"
        },
        {
          "source": "n_rp_thalidomide",
          "target": "n_adv_thalidomide",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_thalidomide",
          "target": "H12",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消效益"
        }
      ],
      "round_index": 2
    },
    "history": {
      "round": 2
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_acitretin",
          "name": "Acitretin"
        },
        "score": 0.76,
        "graph_snapshot_ref": "GE_H1_round2",
        "key_assumptions": [
          "Acitretin 对皮肤炎症有效",
          "相关免疫机制支持作用"
        ],
        "caveats": [
          "潜在的副作用风险尚未完全评估"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_apremilast",
          "name": "Apremilast"
        },
        "score": 0.75,
        "graph_snapshot_ref": "GE_H2_round2",
        "key_assumptions": [
          "Apremilast 可调节免疫反应",
          "与皮肤炎症机制相关"
        ],
        "caveats": [
          "副作用风险评估需进一步证实"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H3",
        "candidate": {
          "id": "drug_etanercept",
          "name": "Etanercept"
        },
        "score": 0.74,
        "graph_snapshot_ref": "GE_H3_round2",
        "key_assumptions": [
          "Etanercept 能有效抑制免疫反应",
          "与皮肤炎症机制相符"
        ],
        "caveats": [
          "可能的免疫抑制风险需谨慎评估"
        ],
        "confidence": "medium"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Drug→Cutaneous Inflammation→Generalised Pustular Psoriasis",
          "reason": "通路明确且存在支持性机制"
        }
      ],
      "remaining_gaps": [
        "缺乏对每种药物副作用的具体量化评价"
      ]
    },
    "seed_retrospective": {
      "batches": [
        {
          "round": 1,
          "seeds": [
            "seed_a",
            "seed_b"
          ],
          "impact_summary": "初步构建了通路，增强了对药物机制的理解"
        },
        {
          "round": 2,
          "seeds": [
            "seed_c",
            "seed_d"
          ],
          "impact_summary": "药物选择的候选覆盖更广，评估了潜在风险"
        }
      ],
      "lessons": [
        "深入评估药物与皮肤炎症的机制关联是必须的",
        "对药物副作用的多维考量能更好支持推论"
      ]
    },
    "prompt_patches": [
      {
        "role": "Proponent",
        "patch": "关注药物的临床应用证据，强化药物与疾病关联的支持链"
      },
      {
        "role": "Skeptic",
        "patch": "明确指出每种药物可能带来的风险及评估方法"
      }
    ],
    "heuristics": [
      {
        "when": "皮肤炎症相关症状",
        "then": "考虑治疗药物的作用机制及可能副作用"
      },
      {
        "when": "选择药物",
        "then": "优先考虑已有的临床试验数据以支持疗效评估"
      }
    ]
  }
}